What question did this study set out to answer?

The aim is to evaluate how cyclodextrin encapsulation affects the susceptibility of different species of Candida to essential oils.

April 22, 2026Open Access

Species-Specific Susceptibility of Planktonic and Biofilm Forming Candida Strains to Cyclodextrin-Encapsulated Essential Oils

Key Points

The aim is to evaluate how cyclodextrin encapsulation affects the susceptibility of different species of Candida to essential oils.
Tested four essential oils and their cyclodextrin complexes against C. albicans and non-albicans Candida species.
Assessed susceptibility through metabolic viability and biomass metrics in both planktonic and biofilm forms.
Analyzed antioxidant gene expressions using qPCR and employed mixed-effects and classification models to interpret data.
C. albicans showed the lowest susceptibility thresholds, while non-albicans species had higher thresholds.
RAMEB complexation improved efficacy, with thyme oil (RT) being the most effective across conditions.
Biofilm biomass was maintained even when viability decreased, indicating a complex relationship between biomass and activity.

Abstract

Background/Objectives: Essential oils (EOs) have multi-target antifungal activity, but their translation is limited by volatility and poor aqueous dispersibility. Randomly methylated β-cyclodextrin (RAMEB) inclusion may enhance effective exposure and thereby alter susceptibility, stress responses, and biofilm outcomes in a species-dependent manner. This study quantified species-specific planktonic and biofilm susceptibility to four EOs and their RAMEB complexes across clinically relevant Candida species. Methods: Lavender (L), lemon balm (B), peppermint (P), and thyme (T) oils and their RAMEB complexes (RL, RB, RP, and RT) were tested against C. albicans and non-albicans Candida. Susceptibility thresholds were used to derive phase plasticity metrics. Functional inhibition was assessed via planktonic metabolism/viability and established biofilm metabolism/viability/biomass. Mechanistic signatures were captured by ROS/RNS measurements and a qPCR analysis of antioxidant genes (CAT1, GPX1, and SOD1) was performed. Mixed-effects models and multivariate/unsupervised and interpretable classification approaches (k-means, PCA, and CRT) were used to integrate endpoints and stratify response phenotypes. Results: Susceptibility thresholds were strongly species-structured (lowest MIC90/EC10 for C. albicans; higher thresholds and broader sublethal windows in non-albicans species). RAMEB complexation produced formulation-dependent shifts in efficacy, with RT emerging as the most consistent broad-spectrum inhibitory condition across compartments. Biofilm biomass was comparatively insensitive even when viability was suppressed, indicating a decoupling of structural biomass from biocidal activity. Mechanistic signatures were broadly conserved across species and linked to antioxidant-program engagement, with CAT1-related rules contributing to responder/tolerant classification. Conclusions: Integrating MIC/EC plasticity with functional and mechanistic markers supports the rational selection of EO formulations; RAMEB complexation, particularly RT, prioritizes candidates for further pharmaceutical optimization while highlighting species-specific vulnerabilities.

Read Full Paperexternally

AI से पूछें

Bookmark

View Full Paper

Cite This Study

Das et al. (Mon,) studied this question.

synapsesocial.com/papers/69e866c96e0dea528ddeb194 https://doi.org/https://doi.org/10.3390/pharmaceutics18040508

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AI से पूछें

Bookmark

View Full Paper